 | Vorinostat | IC50 | 163.6 [1] |
| Vorinostat | Ki | 7.0 [1] |
 | Trichostatin A | IC50 | 20.5 [1] |
| Trichostatin A | Ki | 0.65 [1], 0.7 [2], 0.76 [3], 1.06 [4], 3.55 [5] |
 | Entinostat | IC50 | 500.0 [1] |
| Entinostat | Ki | 65.0 [1] |
 | Tubastatin A | IC50 | 30000.0 [1] |
| Tubastatin A | Ki | 1130.0 [1] |
 | Panobinostat | IC50 | 3.28 [1] |
| Panobinostat | Ki | 0.65 [1], 0.7 [2], 1.9 [3], 22.0 [4] |
 | Mocetinostat | IC50 | 180.0 [1] |
| Mocetinostat | Ki | 32.4 [1] |
 | Tubacin | IC50 | 260.0 [1], 6270.0 [2] |
| Tubacin | Ki | 42.0 [1], 1180.7 [2] |
 | 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 100.0 [1] |
| 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | Ki | 1.5 [1] |
 | Ricolinostat | IC50 | 48.0 [1] |
 | Dacinostat | IC50 | 5.0 [1], 7.0 [2], 10.0 [3], 15.7 [4] |
| Dacinostat | Ki | 1.4 [1] |
 | N-(4-Aminobiphenyl-3-yl)benzamide | IC50 | 350.0 [1] |
 | N-(2-Aminophenyl)-4-[[[(2S)-3-(1H-indol-3-yl)-2-[(4-methoxybenzoyl)amino]propanoyl]amino]methyl]benzamide | IC50 | 157.1 [1] |
 | Romidepsin | IC50 | 1.0 [1], 6070.0 [2] |
| Romidepsin | Ki | 0.04 [1] |
 | Belinostat | IC50 | 49.0 [1], 50.0 [2] |
| Belinostat | Ki | 0.85 [1], 0.9 [2], 22.0 [3] |
 | Apicidin | IC50 | 1.0 [1], 34.0 [2], 35.0 [3] |
| Apicidin | Ki | 0.12 [1] |
 | Tacedinaline | IC50 | 900.0 [1], 1200.0 [2], 3850.0 [3] |
| Tacedinaline | Ki | 190.0 [1] |
 | N-[(2S)-3-(1H-Indol-3-yl)-1-oxo-1-[[4-(propylaminocarbamoyl)phenyl]methylamino]propan-2-yl]-4-methoxybenzamide | IC50 | 194.0 [1], 259.9 [2], 287.1 [3], 366.9 [4], 423.7 [5] |
 | Largazole | IC50 | 18.65 [1], 900.0 [2], 1010.0 [3], 1720.0 [4] |
 | N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide | IC50 | 31000.0 [1], 50000.0 [2], 100000.0 [3] |
 | Lovastatin | IC50 | 25933.0 [1] |
 | Quisinostat | IC50 | 0.33 [1] |
| Quisinostat | Ki | 0.06 [1], 31.0 [2] |
 | N-(2-Aminophenyl)benzamide | IC50 | 3100.0 [1], 3300.0 [2], 10000.0 [3] |
 | N-Hydroxy-E-3-(biphenyl-4-yl)-acrylamide | IC50 | 820.0 [1] |
 | (5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione | IC50 | 0.9 [1], 4.19 [2] |
 | [4-(4-Amino-biphenyl-3-ylcarbamoyl)-benzyl]-carbamic acid benzyl ester | IC50 | 740.0 [1], 14000.0 [2], 38000.0 [3] |
 | (3S,6S,9S,13S)-3-[[1-[(Dimethylamino)methyl]indol-3-yl]methyl]-9-methyl-13-(2-methylpropyl)-6-propyl-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 1400.0 [1], 1430.0 [2] |
| (3S,6S,9S,13S)-3-[[1-[(Dimethylamino)methyl]indol-3-yl]methyl]-9-methyl-13-(2-methylpropyl)-6-propyl-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | Ki | 33.0 [1] |
 | 4-[4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]-N-hydroxycyclohexane-1-carboxamide | IC50 | 20000.0 [1] |
 | 3-[[4-Ethoxy-3-(3-ethyl-1-methyl-7-oxo-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]methyl]-N-hydroxycyclobutane-1-carboxamide | IC50 | 490.0 [1], 729.0 [2], 1220.0 [3] |
 | N-(2-Amino-5-phenylphenyl)-4-azidobenzamide | IC50 | 210.0 [1], 1050.0 [2], 5130.0 [3] |
 | N-(2-Amino-5-thiophen-2-ylphenyl)-4-azidobenzamide | IC50 | 110.0 [1], 690.0 [2], 3200.0 [3] |
 | N-(2-Amino-5-thiophen-2-ylphenyl)-3-azido-5-(azidomethyl)benzamide | IC50 | 2400.0 [1], 5200.0 [2], 18000.0 [3] |
 | N-(2-Amino-5-phenylphenyl)-3-azido-5-(azidomethyl)benzamide | IC50 | 10000.0 [1], 21000.0 [2], 32000.0 [3] |
 | N-(2-Amino-5-phenylphenyl)-3-azido-4-(2-azidoethoxy)benzamide | IC50 | 830.0 [1], 6500.0 [2], 34000.0 [3] |
 | N-(2-Amino-5-thiophen-2-ylphenyl)-3-azido-4-(2-azidoethoxy)benzamide | IC50 | 750.0 [1], 6600.0 [2], 17000.0 [3] |
 | N-(2-Amino-5-azidophenyl)-4-(3-azidopropanoylamino)benzamide | IC50 | 77000.0 [1], 94000.0 [2], 120000.0 [3] |
 | (3-Azidophenyl)methyl N-[[4-[(2-amino-5-phenylphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 320.0 [1], 1000.0 [2], 3800.0 [3] |
 | [3-Azido-5-(azidomethyl)phenyl]methyl N-[[4-[(2-amino-5-phenylphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 350.0 [1], 1100.0 [2], 7000.0 [3] |
 | [3-Azido-5-(azidomethyl)phenyl]methyl N-[[4-[(2-amino-5-thiophen-2-ylphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 300.0 [1], 1000.0 [2], 7100.0 [3] |
 | Atorvastatin | IC50 | 22547.0 [1] |
 | Scriptaid | IC50 | 700.0 [1] |
| Scriptaid | Ki | 2.2 [1] |
 | Abexinostat | Ki | 19.0 [1], 20.0 [2] |
 | Pracinostat | Ki | 16.0 [1], 27.0 [2] |
 | n,n'-Dihydroxyoctanediamide | IC50 | 8230.0 [1] |
| n,n'-Dihydroxyoctanediamide | Ki | 29.0 [1] |
 | Givinostat | Ki | 3.0 [1] |
 | Fimepinostat | IC50 | 5.0 [1] |
 | HDAC6 Inhibitor | IC50 | 93.0 [1], 252.0 [2] |
 | N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | IC50 | 7450.0 [1] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | Ki | 774.0 [1] |
 | Azumamide E | IC50 | 100.0 [1] |
| Azumamide E | Ki | 50.0 [1] |
 | N-Hydroxy-4-phenylbutanamide | IC50 | 600.0 [1] |
| N-Hydroxy-4-phenylbutanamide | Ki | 430.0 [1] |
 | N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide | IC50 | 1280.0 [1], 1980.0 [2] |
 | 9,9,9-Trifluoro-8-Oxo-N-Phenylnonanamide | IC50 | 1400.0 [1] |
| 9,9,9-Trifluoro-8-Oxo-N-Phenylnonanamide | Ki | 11000.0 [1] |
 | N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide | IC50 | 1250.0 [1], 7380.0 [2] |
 | 4-[2-[2-Hydroxyethyl(Phenyl)amino]-2-Oxidanylidene-Ethyl]-~{n}-Oxidanyl-Benzamide | IC50 | 4400.0 [1] |
 | N'-Hydroxy-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamide | IC50 | 63.9 [1] |
 | Largazole Thiol | IC50 | 0.9 [1] |
 | (E)-N-Hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide | IC50 | 1160.0 [1] |
 | Azumamide C | Ki | 10.0 [1], 40.0 [2] |
 | 6-(1-Adamantylcarbamoylamino)-N-hydroxyhexanamide | IC50 | 1050.0 [1], 2580.0 [2] |
 | CID 24853793 | IC50 | 110.0 [1] |
 | N-(4-Hydroxybiphenyl-3-yl)benzamide | IC50 | 200.0 [1] |
 | (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 36.0 [1], 36.2 [2] |
 | (2S)-N'-Hydroxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyloctanediamide | IC50 | 89.0 [1], 143.0 [2] |
 | (2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamide | IC50 | 12.0 [1] |
 | (E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide | IC50 | 590.0 [1] |
 | (S)-Benzyl 4-(5-(2-aminophenylcarbamoyl)pyridin-2-yl)-2-methylpiperazine-1-carboxylate | IC50 | 272.0 [1], 308.0 [2] |
 | Pyridin-3-ylmethyl N-[[4-[(2-amino-5-thiophen-2-ylphenyl)carbamoyl]phenyl]methyl]carbamate | IC50 | 6.0 [1], 100.0 [2] |
 | N-(2-Amino-5-thiophen-2-ylphenyl)-4-methoxybenzamide | IC50 | 200.0 [1] |
 | 2-(4-Methoxybenzyloxy)-N8-hydroxy-N1-phenyloctanediamide | IC50 | 50.0 [1], 254.0 [2] |
 | (2E,4E)-N-Hydroxy-5-[4-(4-methoxyphenyl)phenyl]penta-2,4-dienamide | IC50 | 5000.0 [1] |
 | N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide | IC50 | 50000.0 [1] |
 | (E)-3-[1'-[(4-Fluorophenyl)methyl]-4-oxospiro[3H-chromene-2,4'-piperidine]-6-yl]-N-hydroxyprop-2-enamide | IC50 | 310.0 [1], 320.0 [2] |
 | (E)-N-Hydroxy-3-[4-oxo-1'-(2-phenylethyl)spiro[3H-chromene-2,4'-piperidine]-6-yl]prop-2-enamide | IC50 | 190.0 [1], 199.0 [2] |
 | (3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-propyl-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 1500.0 [1], 1580.0 [2] |
 | N-[(2S)-1-[4-[(E)-3-(Hydroxyamino)-3-oxoprop-1-enyl]-2-methoxyphenoxy]-3-(1H-indol-3-yl)propan-2-yl]-2-propylpentanamide | IC50 | 321.6 [1], 1420.0 [2] |
 | (2S)-N'-Hydroxy-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-N-[3-(trifluoromethyl)phenyl]octanediamide | IC50 | 8.0 [1] |
 | (2S)-N'-Hydroxy-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]-N-phenyloctanediamide | IC50 | 89.0 [1], 143.0 [2] |
 | (2S)-N'-Hydroxy-N-(3-methylphenyl)-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]octanediamide | IC50 | 27.0 [1] |
 | N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide | IC50 | 16000.0 [1] |
 | (1R,5S)-N-[2-Amino-5-(4-fluorophenyl)phenyl]-8-oxabicyclo[3.2.1]octane-3-carboxamide | IC50 | 1590.0 [1] |
Calculator
